{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:08Z","timestamp":1793039528457,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cca.2024.120011","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T10:06:20Z","timestamp":1729418780000},"page":"120011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Ovarian cancer extracellular vesicle biomarkers"],"prefix":"10.1016","volume":"565","author":[{"given":"Zeinab","family":"Jamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Razipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojat","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Akrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0005","article-title":"CA: a cancer journal for clinicians","volume":"74","author":"Siegel","year":"2024","journal-title":"Cancer Statistics, 2024"},{"issue":"6","key":"10.1016\/j.cca.2024.120011_b0010","doi-asserted-by":"crossref","first-page":"909e16","DOI":"10.3892\/mco.2014.397","article-title":"Features of ovarian cancer in Lynch syndrome (Review)","volume":"2","author":"Nakamura","year":"2014","journal-title":"Mol Clin Oncol."},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","article-title":"Hereditary breast and ovarian cancer: new genes in confined pathways","volume":"16","author":"Nielsen","year":"2016","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.cca.2024.120011_b0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10654-018-0474-9","article-title":"The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study","volume":"34","author":"Lundberg","year":"2019","journal-title":"European Journal of Epidemiology"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0025","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/JOM.0000000000001800","article-title":"Serous ovarian cancer caused by exposure to asbestos and fibrous talc in cosmetic talc powders\u2014a case series","volume":"62","author":"Steffen","year":"2020","journal-title":"Journal of Occupational and Environmental Medicine"},{"key":"10.1016\/j.cca.2024.120011_b0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.reprotox.2019.08.015","article-title":"Critical review of the association between perineal use of talc powder and risk of ovarian cancer","volume":"90","author":"Taher","year":"2019","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.cca.2024.120011_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10552-017-0873-3","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis","volume":"28","author":"Zhou","year":"2017","journal-title":"Cancer Causes & Control"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case\u2013control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.cca.2024.120011_b0045","unstructured":"Medicine, P.C.o.t.A.S.f.R., Electronic address: asrm@ asrm. org; Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril, 2016. 106(7): p. 1634-1647."},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0050","first-page":"2124","article-title":"Strong evidences of the ovarian carcinoma risk in women after IVF treatment: a review article","volume":"48","author":"Farhud","year":"2019","journal-title":"Iranian Journal of Public Health"},{"issue":"24","key":"10.1016\/j.cca.2024.120011_b0055","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1016\/j.cca.2024.120011_b0060","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1055-9965.EPI-16-0011","article-title":"Parity and oral contraceptive use in relation to ovarian cancer risk in older women","volume":"25","author":"McGuire","year":"2016","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.cca.2024.120011_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case\u2013control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0075","first-page":"292","article-title":"Incessant ovulation and ovarian cancer\u2013a hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts, Views & Vision in ObGyn"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1017\/S0025727300000521","article-title":"From the \u201csilent killer\u201d to the \u201cwhispering disease\u201d: ovarian cancer and the uses of metaphor","volume":"53","author":"Jasen","year":"2009","journal-title":"Medical History"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0085","article-title":"Symptoms and risk factors of ovarian cancer: a survey in primary care","volume":"2012","author":"Gajjar","year":"2012","journal-title":"International Scholarly Research Notices"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amepre.2015.09.023","article-title":"A systematic review of symptoms for the diagnosis of ovarian cancer","volume":"50","author":"Ebell","year":"2016","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.cca.2024.120011_b0095","doi-asserted-by":"crossref","unstructured":"Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 20CA: a cancer journal for clinicians, 2069(1): p. 7-34.","DOI":"10.3322\/caac.21551"},{"key":"10.1016\/j.cca.2024.120011_b0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJMcp0901926","article-title":"Clinical practice. Screening for ovarian cancer","volume":"361","author":"Dl","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0105","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/cncr.22594","article-title":"Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened","volume":"109","author":"van Nagell Jr","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.cca.2024.120011_b0115","article-title":"BREAKING GROUND: Latest innovations and therapies in ovarian cancer treatment","author":"Balaji","year":"2024","journal-title":"Obstetrics and Gynaecology Forum."},{"issue":"6","key":"10.1016\/j.cca.2024.120011_b0120","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.cca.2024.120011_b0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00428-020-02757-0","article-title":"The leading role of pathology in assessing the somatic molecular alterations of cancer: Position paper of the european society of pathology","volume":"476","author":"Matias-Guiu","year":"2020","journal-title":"Virchows Archiv"},{"issue":"10","key":"10.1016\/j.cca.2024.120011_b0130","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2174\/1566524013666131111125515","article-title":"Platinum-based agents for individualized Cancer Treatment","volume":"13","author":"Chen","year":"2013","journal-title":"Current Molecular Medicine"},{"issue":"5","key":"10.1016\/j.cca.2024.120011_b0135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3904\/kjim.2017.008","article-title":"Targeted therapy of ovarian cancer including immune check point inhibitor","volume":"32","author":"Kim","year":"2017","journal-title":"The Korean Journal of Internal Medicine"},{"issue":"19","key":"10.1016\/j.cca.2024.120011_b0140","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.3390\/ijms231912041","article-title":"Molecular biomarkers for the early detection of ovarian cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.09.028","article-title":"CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients: From The Danish \u201cMALOVA\u201d ovarian cancer study","volume":"104","author":"H\u00f8gdall","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"707","key":"10.1016\/j.cca.2024.120011_b0150","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.3399\/BJGP.2020.0859","article-title":"CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: A retrospective cohort study using electronic health records","volume":"71","author":"Funston","year":"2021","journal-title":"British Journal of General Practice"},{"key":"10.1016\/j.cca.2024.120011_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1489-4","article-title":"Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer","volume":"16","author":"Gu","year":"2018","journal-title":"Journal of Translational Medicine"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecologic Oncology"},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14737140.2017.1360138","article-title":"The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review","volume":"17","author":"Scaletta","year":"2017","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0170","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1515\/cclm-2021-0510","article-title":"Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics","volume":"59","author":"Lycke","year":"2021","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"2 Part 1","key":"10.1016\/j.cca.2024.120011_b0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/AOG.0b013e318195ad17","article-title":"The accuracy of risk scores in predicting ovarian malignancy: a systematic review","volume":"113","author":"Geomini","year":"2009","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0185","doi-asserted-by":"crossref","first-page":"e22624","DOI":"10.1002\/jcla.22624","article-title":"Diagnostic performance of CA 125, HE 4, and risk of ovarian malignancy algorithm for ovarian cancer","volume":"33","author":"Kim","year":"2019","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0190","first-page":"1743","article-title":"Plasma 5-miRNA as biomarkers for identifying prostate cancer patients","volume":"48","author":"Saffari","year":"2019","journal-title":"Iran J Public Health"},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0195","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/pr100904q","article-title":"Advances in proximal fluid proteomics for disease biomarker discovery","volume":"9","author":"Teng","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.cca.2024.120011_b0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urine.2023.10.001","article-title":"Urine biomarkers can outperform serum biomarkers in certain diseases","volume":"5","author":"Xue","year":"2023","journal-title":"URINE"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13054-021-03698-z","article-title":"Association of cerebrospinal fluid protein biomarkers with outcomes in patients with traumatic and non-traumatic acute brain injury: systematic review of the literature","volume":"25","author":"Santacruz","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12590","article-title":"Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review","volume":"135","author":"Andersen","year":"2017","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0215","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-170680","article-title":"Cerebrospinal fluid biomarkers for early and differential alzheimer's disease diagnosis","volume":"62","author":"Bjerke","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cca.2024.120011_b0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-12-804279-3.00008-3","article-title":"Cerebrospinal fluid in Creutzfeldt-Jakob disease","volume":"146","author":"Zerr","year":"2017","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0225","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jnnp-2021-327503","article-title":"Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis","volume":"93","author":"Dreger","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2024.120011_b0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-804279-3.00009-5","article-title":"Cerebrospinal fluid findings in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathies","volume":"146","author":"Illes","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cca.2024.120011_b0235","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","article-title":"The cerebrospinal fluid in multiple sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal fluid biomarkers for huntington's disease","volume":"5","author":"Byrne","year":"2016","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","article-title":"Fluid biomarkers in frontotemporal dementia: past, present and future","volume":"92","author":"Swift","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2024.120011_b0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2018.05.007","article-title":"Epilepsy biomarkers - toward etiology and pathology specificity","volume":"123","author":"Pitk\u00e4nen","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0255","first-page":"230","article-title":"Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer","volume":"21","author":"Zhang","year":"2023","journal-title":"Cancer Biol Med"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-018-0772-6","article-title":"Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients","volume":"17","author":"Hur","year":"2018","journal-title":"Mol Cancer"},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0265","article-title":"Bronchoalveolar lavage fluid-isolated biomarkers for the diagnostic and prognostic assessment of lung cancer","volume":"12","author":"Kalkanis","year":"2022","journal-title":"Diagnostics (basel)"},{"issue":"10","key":"10.1016\/j.cca.2024.120011_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102589","article-title":"Crucial role of extracellular vesicles in bronchial asthma","volume":"20","author":"Nagano","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MCP.0b013e3283447b60","article-title":"Antigen detection in bronchoalveolar lavage fluid for diagnosis of fungal pneumonia","volume":"17","author":"Hage","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0280","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ajt.12091","article-title":"Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome","volume":"13","author":"Kennedy","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.55730\/1300-0152.2608","article-title":"Point-of-care diagnosis of cervical cancer: potential protein biomarkers in cervicovaginal fluid","volume":"46","author":"K\u00f6se","year":"2022","journal-title":"Turk J Biol"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00216-011-5057-5","article-title":"14\u20133-3 protein beta\/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid","volume":"401","author":"Minamida","year":"2011","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0300","doi-asserted-by":"crossref","first-page":"e201960120","DOI":"10.1002\/jbio.201960120","article-title":"Development of highly reliable SERS-active photonic crystal fiber probe and its application in the detection of ovarian cancer biomarker in cyst fluid","volume":"13","author":"Beffara","year":"2020","journal-title":"J Biophotonics"},{"issue":"7","key":"10.1016\/j.cca.2024.120011_b0305","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.pan.2023.05.005","article-title":"Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis","volume":"23","author":"Pfl\u00fcger","year":"2023","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010159","article-title":"Nipple aspirate fluid at a glance","volume":"14","author":"Patuleia","year":"2021","journal-title":"Cancers (basel)"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0315","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.juro.2013.05.019","article-title":"Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models","volume":"191","author":"Whelan","year":"2014","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.cca.2024.120011_b0320","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1007\/s00432-023-04675-5","article-title":"Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer","volume":"149","author":"Han\u017eek","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.cca.2024.120011_b0325","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/08820139.2019.1691222","article-title":"IL-6 and IL-8 as prognostic factors in peritoneal fluid of ovarian cancer","volume":"49","author":"Rodrigues","year":"2020","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13048-018-0391-2","article-title":"Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers","volume":"11","author":"Yamamoto","year":"2018","journal-title":"J Ovarian Res"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neo.2021.12.008","article-title":"RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer","volume":"24","author":"Hulstaert","year":"2022","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.cca.2024.120011_b0340","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/GME.0000000000001534","article-title":"The accuracy of ascites cytology in diagnosis of advanced ovarian cancer in postmenopausal women prior to neoadjuvant chemotherapy","volume":"27","author":"Baransi","year":"2020","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0345","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2024.120011_b0350","doi-asserted-by":"crossref","first-page":"1142755","DOI":"10.3389\/fonc.2023.1142755","article-title":"Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer","volume":"13","author":"Kong","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0355","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12967-022-03404-9","article-title":"Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites","volume":"20","author":"Luo","year":"2022","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0360","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1039\/D0AN01701A","article-title":"Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites","volume":"146","author":"Schuster-Little","year":"2021","journal-title":"Analyst"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030893","article-title":"Amino acid-metabolizing enzymes in advanced high-grade serous ovarian cancer patients: value of ascites as biomarker source and role for IL4I1 and IDO1","volume":"15","author":"Grobben","year":"2023","journal-title":"Cancers (basel)"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0370","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ygyno.2021.06.028","article-title":"Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer","volume":"162","author":"Werner","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0375","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000472","article-title":"Circulating CD14(high) CD16(low) intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression","volume":"8","author":"Prat","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.cca.2024.120011_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071702","article-title":"Ovarian cancer-associated ascites have high proportions of cytokine-responsive CD56bright NK cells","volume":"10","author":"Tonetti","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020833","article-title":"Ovarian cancer cells in ascites form aggregates that display a hybrid epithelial-mesenchymal phenotype and allows survival and proliferation of metastasizing cells","volume":"23","author":"Capellero","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2024.120011_b0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2018.03.019","article-title":"Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients","volume":"482","author":"Dalal","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.cca.2024.120011_b0395","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1080\/01443615.2022.2151352","article-title":"The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours","volume":"42","author":"Ain","year":"2022","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0400","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.gendis.2022.07.004","article-title":"Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer","volume":"10","author":"Utkarsh","year":"2023","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12672-023-00674-7","article-title":"Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer","volume":"14","author":"Xiong","year":"2023","journal-title":"Discov Oncol"},{"issue":"36","key":"10.1016\/j.cca.2024.120011_b0410","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2015.61.3083","article-title":"Lavage of the uterine cavity for molecular detection of m\u00fcllerian duct carcinomas: a proof-of-concept study","volume":"33","author":"Maritschnegg","year":"2015","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.cca.2024.120011_b0415","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1074\/mcp.RA119.001362","article-title":"Microvesicle proteomic profiling of uterine liquid biopsy for ovarian cancer early detection","volume":"18","author":"Barnabas","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cca.2024.120011_b0420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-94-017-9523-4_5","article-title":"Exosomes in urine biomarker discovery","author":"Huebner","year":"2015","journal-title":"Urine Proteomics in Kidney Disease Biomarker Discovery"},{"issue":"7","key":"10.1016\/j.cca.2024.120011_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071064","article-title":"Extracellular vesicles from uterine aspirates represent a promising source for screening markers of gynecologic cancers","volume":"11","author":"Skryabin","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0430","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.cca.2024.120011_b0435","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0440","article-title":"Extracellular vesicles: new classification and tumor immunosuppression","volume":"12","author":"Sheta","year":"2023","journal-title":"Biology (basel)"},{"key":"10.1016\/j.cca.2024.120011_b0445","doi-asserted-by":"crossref","first-page":"1330400","DOI":"10.3389\/fmolb.2023.1330400","article-title":"Biogenesis and delivery of extracellular vesicles: harnessing the power of EVs for diagnostics and therapeutics","volume":"10","author":"Yu","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cca.2024.120011_b0450","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2023.07.059","article-title":"Extracellular vesicle-embedded materials","volume":"361","author":"Ma","year":"2023","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0455","doi-asserted-by":"crossref","first-page":"24641","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"Journal of Extracellular Vesicles"},{"issue":"6478","key":"10.1016\/j.cca.2024.120011_b0460","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0470","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s42003-020-01642-5","article-title":"Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer","volume":"4","author":"Albino","year":"2021","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1158\/1541-7786.MCR-16-0163","article-title":"Exosomal annexin II promotes angiogenesis and breast cancer metastasis","volume":"15","author":"Maji","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"8","key":"10.1016\/j.cca.2024.120011_b0480","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1074\/mcp.M112.027086","article-title":"Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition","volume":"12","author":"Tauro","year":"2013","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/j.cca.2024.120011_b0485","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.12.009","article-title":"Carcinoma-associated fibroblasts provide operational flexibility in metastasis","volume":"25","author":"De Wever","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12079-020-00548-5","article-title":"microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK\/STAT3 and NF-\u03baB signaling pathways","volume":"14","author":"Masoumi-Dehghi","year":"2020","journal-title":"J Cell Commun Signal"},{"issue":"26","key":"10.1016\/j.cca.2024.120011_b0495","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.7150\/thno.37455","article-title":"Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis","volume":"9","author":"He","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0500","doi-asserted-by":"crossref","first-page":"41330","DOI":"10.1038\/srep41330","article-title":"Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression","volume":"7","author":"Li","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.cca.2024.120011_b0505","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12935-019-0990-z","article-title":"Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0510","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","article-title":"Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion","volume":"13","author":"Tian","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0515","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/1541-7786.MCR-16-0191","article-title":"Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells","volume":"15","author":"Nakamura","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0520","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2008.12.028","article-title":"Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes","volume":"278","author":"Keller","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.cca.2024.120011_b0525","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.omtn.2019.09.032","article-title":"circPUM1 promotes tumorigenesis and progression of ovarian cancer by sponging miR-615-5p and miR-6753-5p","volume":"18","author":"Guan","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cca.2024.120011_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1437-z","article-title":"CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182","volume":"38","author":"Zong","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.cca.2024.120011_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153720","article-title":"Circular RNAs in renal cell carcinoma: Functions in tumorigenesis and diagnostic and prognostic potentials","volume":"229","author":"Sayad","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cca.2024.120011_b0540","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/701390","article-title":"High LIN28A expressing ovarian cancer cells secrete exosomes that induce invasion and migration in HEK293 cells","volume":"2015","author":"Enriquez","year":"2015","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0545","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-021-03490-5","article-title":"Exosomes in ovarian cancer ascites promote epithelial-mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p","volume":"12","author":"Cai","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cca.2024.120011_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118024","article-title":"Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2\/Wnt axis in ovarian cancer","volume":"257","author":"Wang","year":"2020","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.cca.2024.120011_b0555","first-page":"722","article-title":"Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior","volume":"19","author":"Giusti","year":"2018","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"10.1016\/j.cca.2024.120011_b0560","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41388-019-1087-9","article-title":"The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance","volume":"39","author":"Asare-Werehene","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2024.120011_b0565","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2014.05.026","article-title":"Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance","volume":"738","author":"Zhang","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cca.2024.120011_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109539","article-title":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","volume":"68","author":"El-Arabey","year":"2020","journal-title":"Cell Signal"},{"issue":"28","key":"10.1016\/j.cca.2024.120011_b0575","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/s41388-018-0189-0","article-title":"Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3\/Rab proteins","volume":"37","author":"Dorayappan","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0580","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1007\/s13277-015-4289-y","article-title":"Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics","volume":"37","author":"Seyyedi","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cca.2024.120011_b0585","article-title":"miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer","volume":"28","author":"Alharbi","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cca.2024.120011_b0590","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Au Yeung","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2024.120011_b0595","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12935-019-1051-3","article-title":"Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A","volume":"19","author":"Guo","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.cca.2024.120011_b0600","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.omtn.2019.04.027","article-title":"Emerging function and clinical values of exosomal microRNAs in cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cca.2024.120011_b0605","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2018.08.001","article-title":"Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype","volume":"435","author":"Chen","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cca.2024.120011_b0610","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage polarization in the development and progression of ovarian cancers: an overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0615","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0620","doi-asserted-by":"crossref","first-page":"e1362527","DOI":"10.1080\/2162402X.2017.1362527","article-title":"Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72\/HSP105-TLR2\/TLR4 pathway","volume":"6","author":"Shen","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0625","first-page":"749","article-title":"Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity","volume":"25","author":"Peng","year":"2011","journal-title":"Oncol Rep"},{"issue":"6","key":"10.1016\/j.cca.2024.120011_b0630","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neo.2017.03.005","article-title":"Control of tumor initiation by NKG2D naturally expressed on ovarian cancer cells","volume":"19","author":"Cai","year":"2017","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0635","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/2326-6066.CIR-17-0113","article-title":"Exosomes associated with human ovarian tumors harbor a reversible checkpoint of T-cell responses","volume":"6","author":"Shenoy","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0640","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.1801041","article-title":"Sialic acid-dependent inhibition of T cells by exosomal ganglioside GD3 in ovarian tumor microenvironments","volume":"201","author":"Shenoy","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2024.120011_b0645","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.2147\/CMAR.S210568","article-title":"Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0650","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/s41467-019-10979-3","article-title":"Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma","volume":"10","author":"Czystowska-Kuzmicz","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.cca.2024.120011_b0655","doi-asserted-by":"crossref","first-page":"1057484","DOI":"10.3389\/fcell.2023.1057484","article-title":"Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness","volume":"11","author":"Shnaider","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.cca.2024.120011_b0660","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s12253-015-9914-y","article-title":"Evaluation of cell-free urine microRNAs expression for the use in diagnosis of ovarian and endometrial cancers","volume":"21","author":"Z\u00e1vesk\u00fd","year":"2015","journal-title":"A Pilot Study. Pathol Oncol Res"},{"issue":"6","key":"10.1016\/j.cca.2024.120011_b0665","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3892\/or.2015.3937","article-title":"Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma","volume":"33","author":"Zhou","year":"2015","journal-title":"Oncology Reports"},{"issue":"3","key":"10.1016\/j.cca.2024.120011_b0670","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2024.120011_b0675","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.718408","article-title":"Extracellular vesicle molecular signatures characterize metastatic dynamicity in ovarian cancer","volume":"11","author":"Gonda","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.cca.2024.120011_b0680","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13402-019-00486-4","article-title":"The exosomal integrin \u03b15\u03b21\/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration","volume":"43","author":"Li","year":"2020","journal-title":"Cell Oncol (dordr)"},{"issue":"21","key":"10.1016\/j.cca.2024.120011_b0685","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213392","article-title":"Exosomes from human omental adipose-derived mesenchymal stem cells secreted into ascites promote peritoneal metastasis of epithelial ovarian cancer","volume":"11","author":"Qu","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.cca.2024.120011_b0690","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/ijc.27948","article-title":"Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors","volume":"132","author":"Carbotti","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2024.120011_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215735","article-title":"Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer","volume":"542","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0700","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1038\/s41598-020-65628-3","article-title":"Ovarian cancer exosomes trigger differential biophysical response in tumor-derived fibroblasts","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0705","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/or.2017.5697","article-title":"Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0710","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010464","article-title":"Comparative analysis of tumor-associated microRNAs and tetraspanines from exosomes of plasma and ascitic fluids of ovarian cancer patients","volume":"24","author":"Yunusova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0715","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jcb.29834","article-title":"Stomatin is highly expressed in exosomes of different origin and is a promising candidate as an exosomal marker","volume":"122","author":"Skryabin","year":"2021","journal-title":"Journal of Cellular Biochemistry"},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0720","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncy.21442","article-title":"Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions","volume":"122","author":"Cappellesso","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/j.cca.2024.120011_b0725","doi-asserted-by":"crossref","first-page":"e13247","DOI":"10.1371\/journal.pone.0013247","article-title":"Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line","volume":"5","author":"Ohshima","year":"2010","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0730","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13048-024-01471-8","article-title":"Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer","volume":"17","author":"Cooper","year":"2024","journal-title":"J Ovarian Res"},{"issue":"9","key":"10.1016\/j.cca.2024.120011_b0735","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-derived miRNAs and ovarian carcinoma progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.cca.2024.120011_b0740","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-018-04695-7","article-title":"Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface","volume":"9","author":"Tang","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.cca.2024.120011_b0745","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126780","article-title":"Higher EpCAM-positive extracellular vesicle concentration in ascites is associated with shorter progression-free survival of patients with advanced high-grade serous carcinoma","volume":"25","author":"Herzog","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.cca.2024.120011_b0750","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/2326-6066.CIR-15-0086","article-title":"Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade","volume":"3","author":"Kelleher","year":"2015","journal-title":"Cancer Immunol Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124022642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124022642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:04:56Z","timestamp":1741046696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124022642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":150,"alternative-id":["S0009898124022642"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.120011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian cancer extracellular vesicle biomarkers","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.120011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120011"}}